1. Home
  2. WVE vs MBIN Comparison

WVE vs MBIN Comparison

Compare WVE & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.25

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

MBIN

Merchants Bancorp

HOLD

Current Price

$49.54

Market Cap

2.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
MBIN
Founded
2012
1990
Country
Singapore
United States
Employees
N/A
735
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.3B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
WVE
MBIN
Price
$7.25
$49.54
Analyst Decision
Strong Buy
Buy
Analyst Count
16
3
Target Price
$29.50
$43.67
AVG Volume (30 Days)
6.4M
152.8K
Earning Date
04-28-2026
04-28-2026
Dividend Yield
N/A
0.81%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,704,000.00
N/A
Revenue This Year
N/A
$31.76
Revenue Next Year
$85.67
$3.73
P/E Ratio
N/A
$12.29
Revenue Growth
149.43
N/A
52 Week Low
$5.02
$27.25
52 Week High
$21.73
$50.26

Technical Indicators

Market Signals
Indicator
WVE
MBIN
Relative Strength Index (RSI) 34.60 73.03
Support Level $6.93 $40.82
Resistance Level $7.67 N/A
Average True Range (ATR) 0.33 1.23
MACD 0.23 0.27
Stochastic Oscillator 47.80 88.62

Price Performance

Historical Comparison
WVE
MBIN

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About MBIN Merchants Bancorp

Merchants Bancorp is a United States-based bank holding company operating multiple lines of business focused on FHA multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. Its segments include Multi-family Mortgage Banking, which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing, which offers mortgage warehouse financing, commercial loans and deposit services; and the Banking segment, which generates maximum revenue and provides portfolio lending for multi-family and healthcare facility loans, residential mortgage banking, agricultural lending, SBA lending and community banking.

Share on Social Networks: